MG

Mala Gupta

Active Director Director DIN 08408747
DIN 08408747 First appointment Apr 2019 Primary industry Chemicals
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Apr 2019
Shareholding value •••• Premium profile

About Mala Gupta

Data last updated:

Mala Gupta is a Director at Klystron Biomed Private Limited (since 2019). The company operates in Chemicals. Klystron Biomed Private Limited reported revenue of ₹3 Lakh (FY 2022).

DIN 08408747
Primary Designation Director
Industry Chemicals
First Appointment 01 Apr 2019
Oldest Company Age 7 yrs
Largest company Klystron Biomed Private Limited · ₹3 Lakh (FY 2022)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Klystron Biomed Private Limited U24111UP2019PTC115379
Director01 Apr 20192019₹3 Lakh (FY 2022)Active

Board colleagues of Mala Gupta

NameDINCompanyDesignation
Nitin Gupta08408746Klystron Biomed Private LimitedDirector

Directorship timeline

Open interactive timeline →
Klystron Biomed Private Limited
Premium access

Shareholding and investment profile for Mala Gupta

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Mala Gupta

Mala Gupta currently holds 1 directorship: Klystron Biomed Private Limited (Director, since 01 Apr 2019, revenue ₹3 Lakh (FY 2022)).

Mala Gupta was first appointed on 01 Apr 2019 as Director at Klystron Biomed Private Limited.

The current boards of Mala Gupta's companies include Nitin Gupta (Klystron Biomed Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available